Transient receptor potential (TRP) channels: A clinical perspective

British Journal of Pharmacology

Volumn 171, Issue 10, 2014, Pages 2474-2507

  Kaneko, Yosuke ^a   Szallasi, Arpad ^b  

^a ONO PHARMACEUTICAL CO   (Japan)

^b MONMOUTH MEDICAL CENTER   (United States)

Author keywords

Bladder disorders; Cancer; Pain; Respiratory disorders; TRP channels; TRPA1; TRPCs; TRPM8; TRPV1; TRPV3; TRPV4

Indexed keywords

TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M3; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 3; VANILLOID RECEPTOR 4; AGENTS AFFECTING WATER, MOLECULE OR ION TRANSPORT; LIGAND;

BLADDER DISEASE; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; INFLAMMATORY BOWEL DISEASE; KIDNEY DISEASE; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR PATHOLOGY; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RESPIRATORY TRACT DISEASE; REVIEW; SKIN DISEASE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; DRUG EFFECTS; GENETICS; METABOLISM; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; DRUG DESIGN; HUMANS; LIGANDS; MEMBRANE TRANSPORT MODULATORS; MOLECULAR STRUCTURE; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 84890749065     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12414     Document Type: Review

References (421)

1. AbouAlaiwi WA, Takahashi M, Mell BR, Jones TJ, Ratnam S, Kolb RJ, et al. (2009). Ciliary polycystin-2 is a mechanosensitive calcium channel involved in nitric oxide signaling cascades. Circ Res 104: 860-869.
2. Abriel H, Syam N, Sottas V, Amarouch MY, Rougier JS, (2012). TRPM4 channels in the cardiovascular system: physiology, pathophysiology, and pharmacology. Biochem Pharmacol 84: 873-881.
3. Adebiyi A, Zhao G, Narayanan D, Thomas-Gatewood CM, Bannister JP, et al. (2010). Isoform-selective physical coupling of TRPC3 channels to IP3 receptors in smooth muscle cells regulates arterial contractility. Circ Res 106: 1603-1612.
4. Ahern GP, (2003). Activation of TRPV1 by the satiety factor oleoylethanolamide. J Biol Chem 278: 30429-30434.
5. Aizawa N, Wyndaele JJ, Homma Y, Igawa Y, (2012). Effects of TRPV4 cation channel activation on the primary bladder afferent activities of the rat. Neurourol Urodyn 31: 148-155.
6. Akbar A, Yiangou F, Facer P, Walters JR, Anand P, Ghosh S, (2008). Increased capsaicin receptor TRPV1-expressing sensory nerve fibers in irritable bowel syndrome and their correlation with abdominal pain. Gut 57: 923-929.
7. Alessandri-Haber N, Dina OA, Joseph EK, Reichling D, Levine JD, (2006). A transient receptor potential vanilloid 4-dependent mechanism of hyperalgesia is engaged by concerted action of inflammatory mediators. J Neurosci 26: 3864-3874.
8. Alessandri-Haber N, Dina OA, Joseph EK, Reichling DB, Levine JD, (2008). Interaction of transient receptor potential vanilloid 4: integrin, and SRC tyrosine kinase in mechanical hyperalgesia. J Neurosci 28: 1046-1057.
9. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Catterall WA, Spedding M, Peters JA, Harmar AJ, and CGTP Collaborators (2013). The Concise Guide to PHARMACOLOGY 2013/14: Overview. Br J Pharmacol 170: 1449-1867.
10. Ambrosino P, Soldovieri MV, Russo C, Taglialatela M, (2013). Activation and desensitization of TRPV1 channels in sensory neurons by the PPARα agonist palmitoylethanolamide. Br J Pharmacol 168: 1430-1444.
11. Anand U, Otto WR, Facer P, Zebda N, Selmer I, Gunthorpe MJ, et al. (2008). TRPA1 receptor localization in the human peripheral nervous system and functional studies in cultured human and rat sensory neurons. Neurosci Lett 438: 221-227.
12. Andrade EL, Ferreira J, André E, Calixto JB, (2006). Contractile mechanisms coupled to TRPA1 receptor activation in rat urinary bladder. Biochem Pharmacol 72: 104-114.
13. Andrade EL, Forner S, Bento AF, Leite DF, Dias MA, Leal PC, et al. (2011). TRPA1 receptor modulation attenuates bladder overactivity induced by spinal cord injury. Am J Physiol Renal Physiol 300: F1223-F1234.
14. Andrè E, Campi B, Trevisani M, Ferreira J, Malheiros A, Yunes RA, et al. (2006). Pharmacological characterisation of the plant sesquiterpenes polygodial and drimanial as vanilloid receptor agonists. Biochem Pharmacol 71: 1248-1254.
15. Andrè E, Campi B, Materazzi S, Trevisani M, Amadesi S, Massi D, et al. (2008). Cigarette smoke-induced neurogenic inflammation is mediated by alpha,beta-unsaturated aldehydes and the TRPA1 receptor in rodents. J Clin Invest 118: 2574-2582.
16. Andrè E, Gatti R, Trevisani M, Preti D, Baraldi PG, Patacchini R, et al. (2009). Transient receptor potential ankyrin receptor 1 is a novel target for pro-tussive agents. Br J Pharmacol 158: 1621-1628.
17. Asakawa M, Yoshioka T, Matsutani T, Hikita I, Suzuki M, Oshima I, et al. (2006). Association of a mutation in TRPV3 with defective hair growth in rodents. J Invest Dermatol 126: 2664-2672.
18. Auer-Grumbach M, Olschewski A, Papic̈ L, Kremer H, McEntagart ME, Uhrig S, et al. (2010). Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C. Nat Genet 42: 160-164.
19. Avelino A, Charrua A, Frias B, Cruz C, Boudes M, de Ridder D, et al. (2013). Transient receptor potential channels in bladder function. Acta Physiol (Oxf) 207: 110-122.
20. Bagal SK, Brown AD, Cox PJ, Omoto K, Owen RM, Pryde DC, et al. (2013). Ion channels as therapeutic targets: a drug discovery perspective. J Med Chem 56: 593-624.
21. Bandell M, Story GM, Hwang SW, Viswanath V, Eid SR, Petrus MJ, et al. (2004). Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 41: 849-857.
22. Bang S, Kim KY, Yoo S, Lee SH, Hwang SW, (2007). Transient receptor potential V2 expressed in sensory neurons is activated by probenecid. Neurosci Lett 425: 120-125.
23. Bang S, Yoo S, Yang TJ, Cho H, Hwang SW, (2010a). Farnesyl pyrophosphate is a novel pain-producing molecule via specific activation of TRPV3. J Biol Chem 285: 19362-19371.
24. Bang S, Yoo S, Yang TJ, Cho H, Kim YG, Hwang SW, (2010b). Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. Br J Pharmacol 161: 707-720.
25. Bang S, Yoo S, Yang TJ, Cho H, Hwang SW, (2011). Isopentenyl pyrophosphate is a novel antinociceptive substance that inhibits TRPV3 and TRPA1 ion channels. Pain 152: 1156-1164.
26. Bang S, Yoo S, Yang TJ, Cho H, Hwang SW, (2012). Nociceptive and pro-inflammatory effects of dimethylallyl pyrophosphate via TRPV4 activation. Br J Pharmacol 166: 1433-1443.
27. Basora N, Boulay G, Bilodeau L, Rousseau E, Payet MD, (2003). 20-hydroxyeicosatetraenoic acid (20-HETE) activates mouse TRPC6 channels expressed in HEK293 cells. J Biol Chem 278: 31709-31716.
28. Bautista DM, Movahed P, Hinman A, Axelsson HE, Sterner O, Högestätt ED, et al. (2005). Pungent products from garlic activate the sensory ion channel TRPA1. Proc Natl Acad Sci U S A 102: 12248-12252.
29. Bautista DM, Jordt SE, Nikai T, Tsuruda PR, Read AJ, Poblete J, et al. (2006). TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 124: 1269-1282.
30. Bautista DM, Siemens J, Glazer JM, Tsuruda PR, Basbaum AI, Stucky CL, et al. (2007). The menthol receptor TRPM8 is the principal detector of environmental cold. Nature 448: 204-208.
31. Becker EB, Oliver PL, Glitsch MD, Banks GT, Achilli F, Hardy A, et al. (2009). A point mutation in TRPC3 causes abnormal Purkinje cell development and cerebellar ataxia in moonwalker mice. Proc Natl Acad Sci U S A 106: 6706-6711.
32. Behrendt HJ, Germann T, Gillen C, Hatt H, Jostock R, (2004). Characterization of the mouse cold-menthol receptor TRPM8 and vanilloid receptor type-1 VR1 using a fluorometric imaging plate reader (FLIPR) assay. Br J Pharmacol 141: 737-745.
33. Belvisi MG, Dubuis E, Birrell MA, (2011). Transient receptor potential A1 channels: insights into cough and airway inflammatory disease. Chest 140: 1040-1047.
34. Bessac BF, Sivula M, von Hehn CA, Escalera J, Cohn L, Jordt SE, (2008). TRPA1 is a major oxidant sensor in murine airway sensory neurons. J Clin Invest 118: 1899-1910.
35. Bhat JM, Bielefeldt K, (2006). Capsaicin receptor (TRPV1) and non-erosive reflux disease. Eur J Gastroenterol Hepatol 18: 263-270.
36. Binder A, May D, Baron R, Maier C, Tölle TR, Treede RD, et al. (2010). Transient receptor potential channel polymorphisms are associated with the somatosensory function in neuropathic pain patients. PLoS One 6: e17387.
37. Birder LA, Nakamura Y, Kiss S, Nealen ML, Barrick S, Kanai AJ, et al. (2002). Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci 5: 856-860.
38. Birder LA, Kullmann FA, Lee H, Barrick S, de Groat W, Kanai A, et al. (2007). Activation of urothelial transient receptor potential vanilloid 4 by 4alpha-phorbol 12,13-didecanoate contributes to altered bladder reflexes in the rat. J Pharmacol Exp Ther 323: 227-235.
39. Birrell MA, Belvisi MG, Grace M, Sadofsky L, Faruqi S, Hele DJ, et al. (2009). TRPA1 agonists evoke coughing in guinea pig and human volunteers. Am J Respir Crit Care Med 180: 1042-1047.
40. Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, et al. (2001). Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol 134: 845-852.
41. Blackshaw LA, Brierley SM, Harrington AM, Hughes PA, (2013). TRP channels in visceral pain. Open Pain J 6: 23-30.
42. Bley K, (2012). Effects of topical capsaicin on cutaneous innervation: implications for pain management. Open Pain J 5: 23-28.
43. Boesmans W, Owsianik G, Tack J, Voets T, Vanden Berghe P, (2011). TRP channels in neurogastroenterology: opportunities for therapeutic intervention. Br J Pharmacol 162: 18-37.
44. Bohlen CJ, Priel A, Zhou S, King D, Siemens J, Julius D, (2010). A bivalent tarantula toxin activates the capsaicin receptor, TRPV1, by targeting the outer pore domain. Cell 141: 834-845.
45. Borbírõ I, Lisztes E, Tõth BI, Czifra G, Oláh A, Szöllösi AG, et al. (2011). Activation of transient receptor potential vanilloid-3 inhibits human hair growth. J Invest Dermatol 131: 1605-1614.
46. Brederson JD, Kym PR, Szallasi A, (2013). Targeting TRP channels for pain relief. Eur J Pharmacol 716: 61-76.
47. Breneman DL, Cardone JS, Blumsack RF, Lather RM, Searle EA, Pollack VE, (1992). Topical capsaicin for treatment of hemodialysis-related pruritus. J Am Acad Dermatol 26: 91-94.
48. Brierley SM, Page AJ, Hughes PA, Adam B, Liebregts T, Cooper NJ, et al. (2008). Selective role for TRPV4 ion channels in visceral sensory pathways. Gastroenterol 134: 2059-2069.
49. Brixel LR, Monteilh-Zoller MK, Ingenbrandt CS, Fleig A, Penner R, Enklaar T, et al. (2010). TRPM5 regulates glucose-stimulated insulin secretion. Pflugers Arch 460: 69-76.
50. Brown DC, Iadarola MJ, Perkowski SZ, Erin H, Shofer F, Laszlo KJ, et al. (2005). Physiologic and antinociceptive effects of intrathecal resiniferatoxin in a canine bone cancer model. Anesthesiology 103: 1052-1059.
51. Btesh J, Fischer MJ, Stott K, McNaughton PA, (2013). Mapping the binding site of TRPV1 on AKAP79: implications for inflammatory hyperalgesia. J Neurosci 33: 9184-9193.
52. Buday T, Brozmanova M, Biringerova Z, Gavliakova S, Poliacek I, Calkovsky V, et al. (2012). Modulation of cough response by sensory inputs from the nose-role of trigeminal TRPA1 versus TRPM8 channels. Cough 8: 11.
53. Caceres AI, Brackmann M, Elia MD, Bessac BF, del Camino D, D'Amours M, et al. (2009). A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma. Proc Natl Acad Sci USA 106: 9099-9104.
54. Calvo RR, Meegalla SK, Parks DJ, Parsons WH, Ballentine SK, Lubin ML, et al. (2012). Discovery of vinylcycloalkyl-substituted benzimidazole TRPM8 antagonists effective in the treatment of cold allodynia. Bioorg Med Chem Lett 22: 1903-1907.
55. Canning BJ, (2006). Anatomy and neurophysiology of the cough reflex: ACCP evidence-based clinical practice guidelines. Chest 129: 33-47.
56. Cantero-Recasens G, Gonzalez JR, Fandos C, Duran-Tauleria E, Smit LA, Kauffmann F, et al. (2010). Loss of function of transient receptor potential vanilloid 1 (TRPV1) genetic variant is associated with lower risk of active childhood asthma. J Biol Chem 285: 27532-27535.
57. Capasso R, Aviello G, Romano B, Borrelli F, De Petrocellis L, Di Marzo V, et al. (2012). Modulation of mouse gastrointestinal motility by allyl isothiocyanate, a constituent of cruciferous vegetables (Brassicaceae): evidence for TRPA1-independent effects. Br J Pharmacol 165: 1966-1977.
58. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D, (1997). The capsaicin receptor: a heat-Activated ion channel in the pain pathway. Nature 389: 816-824.
59. Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, et al. (2000). Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288: 306-313.
60. Cathcart CJ, Johnson SA, Reynolds LR, Al-Nadaf S, Budsberg SC, (2012). Efficacy of ABT-116, an antagonist of the transient receptor potential vanilloid type 1, in providing analgesia for dogs with chemically induced synovitis. Am J Vet Res 73: 19-26.
61. Cavanaugh DJ, Chesler AT, Jackson AC, Sigal YM, Yamanaka H, Grant R, et al. (2011). Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells. J Neurosci 31: 5067-5077.
62. Cenac N, Altier C, Chapman K, Liedtke W, Zamponi G, Vergnolle N, (2008). Transient receptor potential vanilloid-4 has a major role in visceral hypersensitivity symptoms. Gastroenterology 135: 937-946.
63. Charrua A, Cruz CD, Cruz F, Avelino A, (2007). Transient receptor potential vanilloid subfamily 1 is essential for the generation of noxious bladder input and bladder overactivity in cystitis. J Urol 177: 1537-1541.
64. Charrua A, Cruz CD, Narayanan S, Gharat L, Gullapalli S, Cruz F, et al. (2009). GRC-6211, a new oral specific TRPV1 antagonist, decreases bladder overactivity and noxious bladder input in cystitis animal models. J Urol 181: 379-386.
65. Chen HC, Xie J, Zhang Z, Su LT, Yue L, Runnels LW, (2010). Blockade of TRPM7 channel activity and cell death by inhibitors of 5-lipoxygenase. PLoS One 5: e11161.
66. Chen J, Joshi SK, DiDomenico S, Perner RJ, Mikusa JP, Gauvin DM, et al. (2011). Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation. Pain 152: 1165-1172.
67. Cheng W, Sun C, Zheng J, (2010). Heteromerization of TRP channel subunits: extending functional diversity. Protein Cell 1: 802-810.
68. Chizh BA, O'Donnell MB, Napolitano A, Wang J, Brooke AC, Aylott MC, et al. (2007). The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans. Pain 132: 132-141.
69. Chu CJ, Huang SM, De Petrocellis L, Bisogno T, Ewing SA, Miller JD, et al. (2003). N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. J Biol Chem 278: 13633-13639.
70. Chuang HH, Prescott ED, Kong H, Shields S, Jordt SE, Basbaum AI, et al. (2001). Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 411: 957-962.
71. Chubanov V, Mederos y Schnitzler M, Meißner M, Schäfer S, Abstiens K, Hofmann T, et al. (2012). Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7. Br J Pharmacol 166: 1357-1376.
72. Clapham DE, (2003). TRP channels as cellular sensors. Nature 426: 517-524.
73. Clapham DE, Runnels LW, Strübing C, (2001). The TRP ion channel family. Nat Rev Neurosci 2: 387-396.
74. Clare JJ, (2010). Targeting ion channels for drug discovery. Discov Med 9: 253-260.
75. Colburn RW, Lubin ML, Stone DJ Jr, Wang Y, Lawrence D, D'Andrea MR, et al. (2007). Attenuated cold sensitivity in TRPM8 null mice. Neuron 54: 379-386.
76. Colsoul B, Schraenen A, Lemaire K, Quintens R, Van Lommel L, Segal A, et al. (2010). Loss of high-frequency glucose-induced Ca2+ oscillations in pancreatic islets correlates with impaired glucose tolerance in Trpm5-/- mice. Proc Natl Acad Sci U S A 107: 5208-5213.
77. Colsoul B, Nilius B, Vennekens R, (2013). Transient receptor potential (TRP) cation channels in diabetes. Curr Top Med Chem 13: 258-269.
78. Cosens DJ, Manning A, (1969). Abnormal electroretinogram from a Drosophila mutant. Nature 224: 285-287.
79. Cromer BA, McIntyre P, (2008). Painful toxins acting on TRPV1. Toxicon 51: 163-173.
80. Cruz F, Dinis P, (2007). Resiniferatoxin and botulinum toxin type A for treatment of lower urinary tract symptoms. Neurourol Urodyn 26: 920-927.
81. Cruz F, Guimaräes M, Silva C, Reis M, (1997). Suppression of bladder hyperreflexia by intravesical resiniferatoxin. Lancet 350: 640-641.
82. Cui M, Honore P, Zhong C, Gauvin G, Mikusa J, Hernandez G, et al. (2006). TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists. J Neurosci 26: 9385-9393.
83. D'Aldebert E, Cenac N, Rousset P, Martin L, Rolland C, Chapman K, et al. (2011). Transient receptor potential vanilloid 4 activated inflammatory signals by intestinal epithelial cells and colitis in mice. Gastroenterology 140: 175-285.
84. Davis JB, Gray J, Gunthorpe MJ, Hatcher JP, Davey PT, Overend P, et al. (2000). Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 405: 183-187.
85. De Petrocellis L, Vellani V, Schiano-Morinello A, Marini P, Magherini PC, Orlando P, et al. (2008). Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyryn type-1 and melastatin-8. Br J Pharmacol 325: 1007-1015.
86. De Petrocellis L, Ligresti A, Morinello AS, Allara M, Bisogno T, Petrosino S, et al. (2011). Effects of cannabinoids and cannabinoid-enriched cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol 163: 1479-1494.
87. DeFalco J, Steiger D, Dourado M, Emerling D, Duncton MA, (2010). 5-benzyloxytryptamine as an antagonist of TRPM8. Bioorg Med Chem Lett 20: 7076-7079.
88. Delescluse I, Mace H, Adcock JJ, (2012). Inhibition of airway hyper-responsiveness by TRPV1 antagonists (SB-705498 and PF-04065463) in the unanaesthetized, ovalbumin-sensitized guinea pig. Br J Pharmacol 166: 1822-1832.
89. Dessaint J, Yu W, Krause JE, Yue L, (2004). Yohimbine inhibits firing activities of rat dorsal root ganglion neurons by blocking Na+ channels and vanilloid VR1 receptors. Eur J Pharmacol 485: 11-20.
90. Dickenson AH, Dray A, (1991). Selective antagonism of capsaicin by capsazepine: evidence for a spinal receptor site in capsaicin-induced antinociception. Br J Pharmacol 104: 1045-1049.
91. Dietrich A, Mederos Y Schnitzler M, Gollasch M, Gross V, Storch U, Dubrovska G, et al. (2005). Increased vascular smooth muscle contractility in TRPC6-/- mice. Mol Cell Biol 25: 6980-6989.
92. Dong XP, Cheng X, Mills E, Delling M, Wang F, Kurtz T, et al. (2008). The type IV mucolipidosis-Associated protein TRPML1 is an endolysosomal iron release channel. Nature 455: 992-996.
93. Du S, Araki I, Yoshiyama M, Nomura T, Takeda M, (2007). Transient receptor potential channel A1 involved in sensory transduction of rat urinary bladder through C-fiber pathway. Urology 70: 826-831.
94. Du S, Araki I, Kobayashi H, Zakoji H, Sawada N, Takeda M, (2008). Differential expression profile of cold (TRPA1) and cool (TRPM8) receptors in human urogenital organs. Urology 72: 450-455.
95. Duncan LM, Deeds J, Hunter J, Shao J, Holmgren LM, Woolf EA, et al. (1998). Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Res 58: 1515-1520.
96. Earley S, (2012). TRPA1 channels in the vasculature. Br J Pharmacol 167: 13-22.
97. Eckel J, Lavin PJ, Finch EA, Mukerji N, Burch J, Gbadegesin R, et al. (2011). TRPC6 enhances angiotensin II-induced albuminuria. J Am Soc Nephrol 22: 526-535.
98. Edelmayer RM, Le LN, Yan J, Wei X, Nassini R, Materazzi S, et al. (2012). Activation of TRPA1 on dural afferents: a potential mechanism of headache pain. Pain 153: 1949-1958.
99. Eder P, Molkentin JD, (2011). TRPC channels as effectors of cardiac hypertrophy. Circ Res 108: 265-272.
100. Eid SR, (2011). The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans. Pain 132: 132-141.
101. Eid SR, Crown ED, Moore EL, Liang HA, Choong KC, Dima S, et al. (2008). HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity. Mol Pain 4: 48.
102. Eisfeld J, Lückhoff A, (2007). TRPM2. Hand Exp Pharmacol 179: 237-252.
103. Ellis CN, Berberian B, Sulica VI, Dodd WA, Jarratt MT, Katz HI, et al. (1993). A double-blind evaluation of topical capsaicin in pruritic psoriasis. J Am Acad Dermatol 29: 438-442.
104. Engel MA, Becker C, Reeh PW, Neurath MF, (2011). Role of sensory neurons in colitis: increasing evidence for a neuroimmune link in the gut. Inflamm Bowel Dis 17: 1030-1033.
105. Everaerts W, Zhen X, Ghosh D, Vriens J, Gevaert T, Gilbert JP, et al. (2010a). Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis. Proc Natl Acad Sci U S A 107: 19084-19089.
106. Everaerts W, Vriens J, Owsianik G, Appendino G, Voets T, De Ridder D, et al. (2010b). Functional characterization of transient receptor potential channels in mouse urothelial cells. Am J Physiol Renal Physiol 298: F692-F701.
107. Facer P, Casula MA, Smith GD, Benham CD, Chessell IP, Bountra C, et al. (2007). Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy. BMC Neurol 7: 11.
108. Faul C, Asanuma K, Yanagida-Asanuma E, Kim K, Mundel P, (2007). Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol 17: 428-437.
109. Fernandes ES, Fernandes MA, Keeble JE, (2012). The functions of TRPA1 and TRPV1: movign away from sensory nerves. Br J Pharmacol 166: 510-521.
110. Fernandes ES, Vong CT, Quek S, Cheong J, Awal S, Gentry C, et al. (2013). Superoxide generation and leukocyte accumulation: key elements in the mediation of leukotriene B4-induced itch by transient receptor potential ankyrin 1 and transient receptor potential vanilloid 1. FASEB J 27: 1664-1673.
111. Fichna J, Mokrowieczka A, Cygankiewicz AI, Zakrzewski PA, Malecka-Panas E, Janecka A, et al. (2012). Transient receptor potential vanilloid 4 blockade protects against experimental colitis in mice: a new strategy for inflammatory bowel disease treatment? Neurogastroenterol Motil 24: e557-e560.
112. Fischer MJ, Betsh J, McNaughton PA, (2013). Disrupting sensitization of transient receptor potential vanilloid subtype 1 inhibits inflammatory hyperalgesia. J Neurosci 33: 7407-7414.
113. Flemming PK, Dedman AM, Xu SZ, Li J, Zeng F, Naylor J, et al. (2006). Sensing of lysophospholipids by TRPC5 calcium channel. J Biol Chem 281: 4977-4982.
114. Fujino K, de la Fuente SG, Takami Y, Takahashi G, Mantyh CR, (2006). Attenuation of acid-induced esophagitis in VR-1 deficient mice. Gut 55: 34-40.
115. Garami A, Pakai E, Oliveira DL, Steiner AA, Wanner SP, Almeida MC, et al. (2011). Thermoregulatory phenotype of the Trpv1 knockout mouse: thermoeffector dysbalance with hyperkinesis. Neurosci 31: 1721-1733.
116. Garrison SR, Stucky CL, (2011). The dynamic TRPA1 channel: a suitable pharmacological target? Curr Pharm Biotechnol 12: 1689-1697.
117. Gavva NR, (2008). Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1. Trends Pharmacol Sci 29: 550-557.
118. Gavva NR, Treanor JJ, Garami A, Fang L, Surapaneni S, Akrami A, et al. (2008). Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain 136: 202-210.
119. Gevaert T, Vriens J, Segal A, Everaerts W, Roskams T, Talavera K, et al. (2007). Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding. J Clin Invest 117: 3453-3462.
120. Gomtsyan A, Faltynek C, (eds) (2010). Vanilloid Receptor TRPV1 in Drug Discovery: Targeting Pain and Other Pathological Disorders. John Wiley & Sons: Hoboken, NJ.
121. Gopinath P, Wan E, Holdcroft A, Facer P, Davis JB, Smith GD, et al. (2005). Increased capsaicin receptor TRPV1 in skin nerve fibres and related vanilloid receptors TRPV3 and TRPV4 in keratinocytes in human breast pain. BMC Womens Health 5: 2.
122. Goso C, Evengelista S, Tramontana M, Manzini S, Blumberg PM, Szallasi A, (1993). Topical capsaicin administration protects against trinitrobenzene sulfonic acid-induced colitis in the rat. Eur J Pharmacol 249: 185-190.
123. Goswami C, (2012). TRP-mediated cytoskeletal reorganization: implications for disease and drug development. In:, Szallasi A, Bírõ T, (eds). TRP Channels in Drug Discovery. Methods in Pharmacology and Toxicology, Springer Protocols. Humana Press/Springer: New York, Heidelberg, Dordrecht, London, pp. 13-39.
124. Grace M, Birrell MA, Dubuis E, Maher SA, Belvisi MG, (2012). Transient receptor potential channels mediate the tussive response to prostaglandin E2 and bradykinin. Thorax 67: 891-900.
125. Gram DX, Ahren B, Nagy I, Olsen UB, Brand CL, Sundler F, et al. (2007). Capsaicin-sensitive sensory fibers in the islets of Langerhans contribute to defective insulin secretion in Zucker diabetic rat, an animal model for some aspects of human type 2 diabetes. Eur J Neurosci 25: 213-223.
126. Grand T, Demion M, Norez C, Mettey Y, Launay P, Becq F, et al. (2008). 9-phenanthrol inhibits human TRPM4 but not TRPM5 cationic channels. Br J Pharmacol 153: 1697-1705.
127. Grimm C, Kraft R, Schultz G, Harteneck C, (2005). Activation of the melastatin-related cation channel TRPM3 by d-erythro-sphingosine [corrected ]. Mol Pharmacol 67: 798-805.
128. Groneberg DA, Niimi A, Dinh QT, Cosio B, Hew M, Fischer A, et al. (2004). Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough. Am J Respir Crit Care Med 170: 1276-1280.
129. Guilak F, Leddy HA, Liedtke W, (2010). Transient receptor potential vanilloid 4: the sixth sense of the musculoskeletal system? Ann NY Acad Sci 1192: 404-409.
130. Haas ET, Rowland K, Gautam M, (2011). Tooth injury increases expression of the cold sensitive TRP channel TRPA1 in trigeminal neurons. Arch Oral Biol 56: 1604-1609.
131. Hajõs M, Obál F Jr, Jancsõ G, Obál F, (1985). Capsaicin impairs preoptic serotonin-sensitive structures mediating hypothermia in rats. Neurosci Lett 54: 97-102.
132. Hara K, Kokubo Y, Ishiura H, Fukuda Y, Miyashita A, Kuwano R, et al. (2010). TRPM7 is not associated with amyotrophic lateral sclerosis-parkinsonism dementia complex in the Kii peninsula of Japan. Am J Med Genet B Neuropsychiatr Genet 153B: 310-313.
133. Hara Y, Wakamori M, Ishii M, Maeno E, Nishida M, Yoshida T, et al. (2002). LTRPC2 Ca2+-permeable channel activated by changes in redox status confers susceptibility to cell death. Mol Cell 9: 163-173.
134. Hartmann J, Dragicevic E, Adelsberger H, Henning HA, Sumser M, Abramowitz J, et al. (2008). TRPC3 channels are required for synaptic transmission and motor coordination. Neuron 59: 392-398.
135. Hatano N, Suzuki H, Muraki Y, Muraki K, (2013). Stimulation of human TRPA1 channels by clinical concentrations of the antirheumatic drug auranofin. Am J Physiol Cell Physiol 304: C354-C361.
136. Hayashi T, Kondo T, Ishimatsu M, Takeya M, Igata S, Nakamura K, et al. (2011). Function and expression pattern of TRPM8 in bladder afferent neurons associated with bladder outlet obstruction in rats. Auton Neurosci 164: 27-33.
137. Hermosura MC, Cui AM, Go RC, Davenport B, Shetler CM, Heizer JW, et al. (2008). Altered functional properties of a TRPM2 variant in Guamanian ALS and PD. Proc Natl Acad Sci USA 105: 18029-18034.
138. Hill K, McNulty S, Randall AD, (2004a). Inhibition of TRPM2 channels by the antifungal agents clotrimazole and econazole. Naunyn Schmiedebergs Arch Pharmacol 370: 227-237.
139. Hill K, Benham CD, McNulty S, Randall AD, (2004b). Flufenamic acid is a pH-dependent antagonist of TRPM2 channels. Neuropharmacology 47: 450-460.
140. Hisanaga E, Nagasawa M, Ueki K, Kulkarni RN, Mori M, Kojima I, (2009). Regulation of calcium-permeable TRPV2 channel by insulin in pancreatic beta-cells. J Biol Chem 279: 35741-35748.
141. Hoffmann T, Kistner K, Miermeister F, Winkelmann R, Wittmann J, Fischer MJ, et al. (2013). TRPA1 and TRPV1 are differentially involved in heat nociception of mice. Eur J Pain 17: 1472-1482.
142. Holzer P, (2011). Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system. Pharmacol Ther 131: 142-170.
143. Honore P, Wismer CT, Mikusa J, Zhu CZ, Zhong C, Gauvin DM, et al. (2005). A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats. J Pharmacol Exp Ther 314: 410-421.
144. Hu HZ, Gu Q, Wang C, Colton CK, Tang J, Kinoshita-Kawada M, et al. (2004). 2-Aminoethoxydiphenyl borate is a common activator of TRPV1, TRPV2, and TRPV3. J Biol Chem 279: 35741-35748.
145. Huang SM, Bisogno T, Trevisani M, Al-Hayani A, De Petrocellis L, Fezza F, et al. (2002). An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci U S A 99: 8400-8405.
146. Huh D, Leslie DC, Matthews BD, Fraser JP, Jurek S, Hamilton GA, et al. (2012). A human disease model of drug toxicity-induced pulmonary edema in a lung-on-A-chip microdevice. Sci Transl Med 4: 159ra147.
147. Hwang SW, Cho H, Kwak J, Lee SY, Kang CJ, Jung J, et al. (2000). Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci U S A 97: 6155-6160.
148. Iadarola MJ, Gonnella GL, (2013). Resiniferatoxin for pain treatment: an interventional approach to personalized pain medicine. Open Pain J 6: 95-107.
149. Iadarola MJ, Mannes AJ, (2011). The vanilloid agonist resiniferatoxin for interventional-based pain control. Curr Top Med Chem 11: 2171-2179.
150. Igarashi P, Somlo S, (2002). Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol 13: 2384-2398.
151. Imamachi N, Park GH, Lee H, Anderson DJ, Simon MI, Basbaum AI, et al. (2009). TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms. Proc Natl Acad Sci U S A 106: 11330-11335.
152. Ishii M, Shimizu S, Hagiwara T, Wajima T, Miyazaki A, Mori Y, et al. (2006). Extracellular-Added ADP-ribose increases intracellular free Ca2+ concentration through Ca2+ release from stores, but not through TRPM2-mediated Ca2+ entry, in rat beta-cell line RIN-5F. J Pharmacol Sci 101: 174-178.
153. Izzo AA, Capasso R, Aviello G, Borrelli F, Romano B, Piscitelli F, et al. (2012). Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice. Br J Pharmacol 166: 1444-1460.
154. Jeske NA, Patwardhan AM, Ruparel NB, Akopian AN, Shapiro MS, Henry MA, (2009). A-kinase anchoring protein 150 controls protein kinase C-mediated phosphorylation and sensitization of TRPV1. Pain 146: 301-307.
155. Jia Y, Zhou J, Tai Y, Wang Y, (2007). TRPC channels promote cerebellar granule neuron survival. Nat Neurosci 10: 559-567.
156. Jian MY, King JA, Al-Mehdi AB, Liedtke W, Townsley MI, (2008). High vascular pressure-induced lung injury requires P450 epoxygenase-dependent activation of TRPV4. Am J Respir Cell Mol Biol 38: 386-392.
157. Jiang LH, Yang W, Zou J, Beech DJ, (2010). TRPM2 channel properties, functions and therapeutic potentials. Expert Opin Ther Targets 14: 973-988.
158. Jimenez-Andrade JM, Mantyh P, (2010). TRPV1 and bone cancer pain. In:, Gomtsyan A, Faltynek C, (eds). Vanilloid Receptor TRPV1 in Drug Discovery. Targeting Pain and Other Pathological Disorders. John Wiley & Sons: Hoboken, NJ, pp. 191-205.
159. Jordt SE, Bautista DM, Chuang HH, McKemy DD, Zygmunt PM, Högestätt ED, et al. (2004). Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature 427: 260-265.
160. Joshi SK, Honore P, (2010). The role of TRPV1 receptors in osteoarthritic pain. In:, Gomtsyan A, Faltynek C, (eds). Vanilloid Receptor TRPV1 in Drug Discovery. Targeting Pain and Other Pathological Disorders. John Wiley & Sons: Hoboken, NJ, pp. 175-190.
161. Kaczmarek JS, Riccio A, Clapham DE, (2012). Calpain cleaves and activates the TRPC5 channel to participate in semaphorin 3A-induced neuronal growth cone collapse. Proc Natl Acad Sci USA 109: 7888-7892.
162. Kaneko Y, Szallasi A, (2013). TRP channels as therapeutic targets. Curr Top Med Chem 13: 241-243.
163. Keszthelyi D, Troost FJ, Jonkers DM, Helyes Z, Hamer HM, Ludidi S, et al. (2013). Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: a role in pain symptom generation? Eur J Pain 17: 1299-1306.
164. Ketterer C, Müssig K, Heni M, Dudziak K, Randrianarisoa E, Wagner R, et al. (2011). Genetic variation within the TRPM5 locus associates with prediabetic phenotypes in subjects at increased risk for type 2 diabetes. Metabolism 60: 1325-1333.
165. Khairatkar-Joshi N, Maharaj N, Thomas A, (2010). The TRPV3 receptor as a pain target: a therapeutic promise or just some more new biology? Open Drug Discov J 2: 89-97.
166. Kida N, Sokabe T, Kashio M, Haruna K, Mizuno Y, Suga Y, et al. (2012). Importance of transient receptor potential vanilloid 4 (TRPV4) in epidermal barrier function in human skin keratinocytes. Pflugers Arch 463: 715-725.
167. Kitaguchi T, Swartz KJ, (2005). An inhibitor of TRPV1 channels isolated from funnel web spider venom. Biochemistry 44: 15544-15549.
168. Kiyonaka S, Kato K, Nishida M, Mio K, Numaga T, Sawaguchi Y, et al. (2009). Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound. Proc Natl Acad Sci U S A 106: 5400-5405.
169. Klausen TK, Pagani A, Minassi A, Ech-Chahad A, Prenen J, Owsianik G, et al. (2009). Modulation of the transient receptor potential vanilloid channel TRPV4 by 4α-phorbol esters: a structure-Activity study. J Med Chem 52: 2933-2939.
170. Klose C, Straub I, Riehle M, Ranta F, Krautwurst D, Ullrich S, et al. (2011). Fenamates as TRP channel blockers: mefenamic acid selectively blocks TRPM3. Br J Pharmacol 162: 1757-1769.
171. Knotkova H, Pappagallo M, Szallasi A, (2008). Capsaicin (TRPV1 agonist) therapy for pain relief: farewell or revival? Clin J Pain 24: 142-154.
172. Knowlton WM, McKemy DD, (2011). TRPM8: from cold to cancer, peppermint to pain. Curr Pharm Biotechnol 12: 68-77.
173. Kobayashi K, Fukuoka T, Obata K, Yamanaka H, Dai Y, Tokunaga A, et al. (2005). Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with adelta/c-fibers and colocalization with trk receptors. J Comp Neurol 493: 596-606.
174. Koivisto A, Hukkanen M, Saarnilehto M, Chapman H, Kuokkanen K, Wei H, et al. (2012). Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathy. Pharmacol Res 65: 149-158.
175. Kolisek M, Beck A, Fleig A, Penner R, (2005). Cyclic ADP-ribose and hydrogen peroxide synergize with ADP-ribose in the activation of TRPM2 channels. Mol Cell 18: 61-69.
176. Kollarik M, Undem BJ, (2004). Activation of bronchopulmonary vagal afferent nerves with bradykinin, acid and vanilloid receptor agonists in wild-type and TRPV1-/- mice. J Physiol 555: 115-123.
177. Köttgen M, Buchholz B, Garcia-Gonzalez MA, Kotsis F, Fu X, Doerken M, et al. (2008). TRPP2 and TRPV4 form a polymodal sensory channel complex. J Cell Biol 182: 437-447.
178. Kovacs G, Montalbetti N, Simonin A, Danko T, Balazs B, Zsembery A, et al. (2012). Inhibition of the human epithelial calcium channel TRPV6 by 2-Aminoethoxydiphenyl borate (2-APB). Cell Calcium 52: 468-480.
179. Kraft R, Grimm C, Frenzel H, Harteneck C, (2006). Inhibition of TRPM2 cation channels by N-(p-Amylcinnamoyl)anthranilic acid. Br J Pharmacol 148: 264-273.
180. Krall P, Canales CP, Kairath P, Carmona-Mora P, Molina J, Carpio JD, et al. (2010). Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease. PLoS One 5: e12859.
181. Krarup AL, Ny L, Astrand M, Bajor A, Hvid-Jensen F, Hansen MB, et al. (2011). Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain. Pharmacol Ther 33: 1113-1122.
182. Kremeyer B, Lopera F, Cox JJ, Momin A, Rugiero F, Marsh S, et al. (2010). A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome. Neuron 66: 671-680.
183. Kruse M, Schulze-Bahr E, Corfield V, Beckmann A, Stallmeyer B, Kurtbay G, et al. (2009). Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I. J Clin Invest 119: 2737-2744.
184. Kusudo T, Wang Z, Mizuno A, Suzuki M, Yamashita H, (2012). TRPV4 deficiency increases skeletal muscle metabolic capacity and resistance against diet-induced obesity. Appl Physiol 112: 1223-1232.
185. Kuwahara K, Wang Y, McAnally J, Richardson JA, Bassel-Duby R, Hill JA, et al. (2006). TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J Clin Invest 116: 3114-3126.
186. Kyriazis GA, Soundarapandian MM, Tyrberg B, (2012). Sweet taste receptor signaling in beta cells mediates fructose-induced potentiation of glucose-stimulated insulin secretion. Proc Natl Acad Sci U S A 109: E524-E532.
187. Lai-Cheong JE, Sethuraman G, Ramam M, Stone K, Simpson MA, McGrath JA, (2012). Recurrent heterozygous missense mutation, p.Gly573Ser, in the TRPV3 gene in an Indian boy with sporadic Olmsted syndrome. Br J Dermatol 167: 440-442.
188. Landourè G, Zdebik AA, Martinez TL, Burnett BG, Stanescu HC, Inada H, et al. (2010). Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C. Nature Genet 42: 170-174.
189. Lange I, Yamamoto S, Partida-Sanchez S, Mori Y, Fleig A, Penner R, (2009). TRPM2 functions as a lysosomal Ca2+-release channel in beta cells. Sci Signal 2: ra23.
190. LaPlante JM, Ye CP, Quinn SJ, Goldin E, Brown EM, Slaugenhaupt SA, et al. (2004). Functional links between mucolipin-1 and Ca2+-dependent membrane trafficking in mucolipidosis IV. Biochem Biophys Res Commun 322: 1384-1391.
191. Lashinger ES, Steiginga MS, Hieble JP, Leon LA, Gardner SD, Nagilla R, et al. (2008). AMTB, a TRPM8 channel blocker: evidence in rats for activity in overactive bladder and painful bladder syndrome. Am J Physiol Renal Physiol 295: F803-F810.
192. Leamy AW, Shukla P, McAlexander MA, Carr MJ, Ghatta S, (2011). Curcumin ( (E,E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) activates and desensitizes the nociceptor ion channel TRPA1. Neurosci Lett 503: 157-162.
193. Lee SP, Buber MT, Yang Q, Cerne R, Cortés RY, Sprous DG, et al. (2008). Thymol and related alkyl phenols activate the hTRPA1 channel. Br J Pharmacol 153: 1739-1749.
194. Lee YM, Kim YK, Chung JH, (2009). Increased expression of TRPV1 channel in intrinsically aged and photoaged human skin in vivo. Exp Dermatol 18: 431-436.
195. Lee YM, Kang SM, Lee SR, Kong KH, Lee JY, Kim EJ, et al. (2011). Inhibitory effects of TRPV1 blocker on UV-induced responses in the hairless mice. Arch Dermatol Res 303: 727-736.
196. Lehen'kyi V, Prevarskaya N, (2011). Oncogenic TRP channels. Adv Exp Med Biol 704: 929-945.
197. Lei Z, Ishizuka O, Imamura T, Noguchi W, Yamagishi T, Yokoyama H, et al. (2013). Functional roles of transient receptor potential melastatin 8 (TRPM8) channels in the cold stress-induced detrusor overactivity pathways in conscious rats. Neurourol Urodyn 32: 500-504.
198. Leuenroth SJ, Okuhara D, Shotwell JD, Markowitz GS, Yu Z, Somlo S, et al. (2007). Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease. Proc Natl Acad Sci U S A 104: 4389-4394.
199. Leuner K, Kazanski V, Müller M, Essin K, Henke B, Gollasch M, et al. (2007). Hyperforin, a key constituent of St. John's wort, specifically activates TRPC6 channels. FASEB J 21: 4101-4111.
200. Leuner K, Heiser JH, Derksen S, Mladenov MI, Fehske CJ, Schubert R, et al. (2010). Simple 2,4-diacylphloroglucinols as classic transient receptor potential-6 activators-identification of a novel pharmacophore. Mol Pharmacol 77: 368-377.
201. Li J, Kanju P, Patterson M, Chew WL, Cho SH, Gilmour I, et al. (2011b). TRPV4-mediated calcium influx into human bronchial epithelia upon exposure to diesel exhaust particles. Environ Health Perspect 119: 784-793.
202. Li M, Jiang J, Yue L, (2006). Functional characterization of homo- and heteromeric channel kinases TRPM6 and TRPM7. J Gen Physiol 127: 525-537.
203. Li M, Li Q, Yang G, Kolosov VP, Perelman JM, Zhou XD, (2011a). Cold temperature induces mucin hypersecretion from normal human bronchial epithelial cells in vitro through a transient receptor potential melastatin 8 (TRPM8)-mediated mechanism. J Allergy Clin Immunol 128: 626-634.
204. Li Y, Jia YC, Cui K, Li N, Zheng ZY, Wang YZ, et al. (2005). Essential role of TRPC channels in the guidance of nerve growth cones by brain-derived neurotrophic factor. Nature 434: 894-898.
205. Liang J, Xiao G, Ji W, (2011). Capsaicin induces reflex scratching in inflamed skin. Pharmacology 2011: 82-87.
206. Liberati S, Morelli MB, Nabissi M, Santoni M, Santoni G, (2013). Oncogenic and anti-oncogenic effects of transient receptor potential channels. Curr Top Med Chem 13: 344-366.
207. Lin Z, Chen Q, Lee M, Cao X, Zhang J, Ma D, et al. (2012). Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted syndrome. Am J Hum Genet 90: 558-564.
208. Liu BC, Song X, Lu XY, Li DT, Eaton DC, Shen BZ, et al. (2013). High glucose induces podocyte apoptosis by stimulating TRPC6 via elevation of reactive oxygen species. Biochim Biophys Acta 1833: 1434-1442.
209. Liu H, El Zein L, Kruse M, Guinamard R, Beckmann A, Bozio A, et al. (2010). Gain-of-function mutations in TRPM4 cause autosomal dominant isolated cardiac conduction disease. Circ Cardiovasc Genet 3: 374-385.
210. Liu L, Welch JM, Erickson RP, Reinhart PH, Simon SA, (2000). Different responses to repeated applications of zingerone in behavioral studies, recordings from intact and cultured TG neurons, and from VR1 receptors. Physiol Behav 69: 177-186.
211. Liu T, Ji RR, (2012). Oxidative stress induces itch via activation of transient receptor potential subtype ankyrin 1 in mice. Neurosci Bull 28: 145-154.
212. Lysy J, Sistiery-Ittah M, Israelit Y, Shmueli A, Strauss-Liviatan N, Mindrul V, et al. (2003). Topical capsaicin-A novel and effective treatment for idiopathic intractable pruritus ani: a randomised, placebo controlled, crossover study. Gut 52: 1323-1326.
213. Ma S, Yu H, Zhao Z, Luo Z, Chen J, Ni Y, et al. (2012b). Activation of the cold-sensing TRPM8 channel triggers UCP1-dependent thermogenesis and prevents obesity. J Mol Cell Biol 4: 88-96.
214. Ma X, He D, Ru X, Chen Y, Cai Y, Bruce IC, et al. (2012a). Apigenin, a plant-derived flavone, activates transient receptor potential vanilloid 4 cation channel. Br J Pharmacol 166: 349-358.
215. Macpherson LJ, Hwang SW, Miyamoto T, Dubin AE, Patapoutian A, Story GM, (2006). More than cool: promiscuous relationships of menthol and other sensory compounds. Mol Cell Neurosci 32: 335-343.
216. Maggi CA, Barbanti G, Santicioli P, Beneforti P, Misuri D, Meli A, et al. (1989). Cystometric evidence that capsaicin-sensitive nerves modulate the afferent branch of micturition reflex in humans. J Urol 142: 150-154.
217. Majeed Y, Bahnasi Y, Seymour VA, Wilson LA, Milligan CJ, Agarwal AK, et al. (2011a). Rapid and contrasting effects of rosiglitazone on transient receptor potential TRPM3 and TRPC5 channels. Mol Pharmacol 79: 1023-1030.
218. Majeed Y, Amer MS, Agarwal AK, McKeown L, Porter KE, O'Regan DJ, et al. (2011b). Stereo-selective inhibition of transient receptor potential TRPC5 cation channels by neuroactive steroids. Br J Pharmacol 162: 1509-1520.
219. Majeed Y, Tumova S, Green BL, Seymour VA, Woods DM, Agarwal AK, et al. (2012). Pregnenolone sulphate-independent inhibition of TRPM3 channels by progesterone. Cell Calcium 51: 1-11.
220. Malek S, Sample SJ, Schwartz Z, Nemke B, Jacobson PB, Cozzi EM, et al. (2012). Effect of analgesic therapy on clinical outcome measures in a randomized controlled trial using client-owned dogs with hip osteoarthritis. BMC Vet Res 8: 185-191.
221. Marsch R, Foeller E, Rammes G, Bunck M, Kössl M, Holsboer F, et al. (2007). Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. J Neurosci 27: 832-839.
222. Marshall NJ, Liang L, Bodkin J, Dessapt-Baradez C, Nandi M, Collot-Teixeira S, et al. (2013). A role for TRPV1 in influencing the onset of cardiovascular disease in obesity. Hypertension 61: 246-252.
223. Materazzi S, Nassini R, Andrè E, Campi B, Amadesi S, Trevisani M, et al. (2008). Cox-dependent fatty acid metabolites cause pain through activation of the irritant receptor TRPA1. Proc Natl Acad Sci U S A 105: 12045-12050.
224. Mathar I, Vennekens R, Meissner M, Kees F, Van der Mieren G, Camacho Londoño JE, et al. (2010). Increased catecholamine secretion contributes to hypertension in TRPM4-deficient mice. J Clin Invest 120: 3267-3279.
225. Matthews JM, Qin N, Colburn RW, Dax SL, et al. (2012). The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonists. Bioorg Med Chem Lett 22: 2922-2926.
226. Matthews PJ, Aziz Q, Facer P, Davis JB, Thompson DG, Anand P, (2004). Increased capsaicin receptor TRPV1 nerve fibers in the inflamed human oesophagus. Eur J Gastroenterol Hepatol 16: 897-902.
227. McGaraughty S, Chu KL, Perner RJ, Didomenico S, Kort ME, Kym PR, (2010). TRPA1 modulation of spontaneous and mechanically evoked firing of spinal neurons in uninjured, osteoarthritic, and inflamed rats. Mol Pain 6: 14.
228. McKemy DD, Neuhausser WM, Julius D, (2002). Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 416: 52-58.
229. McNamara CR, Mandel-Brehm J, Bautista DM, Siemens J, Deranian KL, Zhao M, et al. (2007). TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci U S A 104: 13525-13530.
230. McNamara FN, Randall A, Gunthorpe MJ, (2005). Effects of piperine, the pungent component of black pepper, at the human vanilloid receptor (TRPV1). Br J Pharmacol 144: 781-790.
231. Meotti FC, Forner S, Lima-Garcia JF, Viana AF, Calixto JB, (2013). Antagonism of the transient receptor potential ankyrin 1 (TRPA1) attenuates hyperalgesia and urinary bladder overactivity in cyclophosphamide-induced haemorrhagic cystitis. Chem Biol Interact 203: 440-447.
232. Miller BA, Zhang W, (2011). TRP channels as mediators of oxidative stress. Adv Exp Med Biol 704: 531-544.
233. Miller M, Shi J, Zhu Y, Kustov M, Tian JB, Stevens A, et al. (2011). Identification of ML204, a novel potent antagonist that selectively modulates native TRPC4/C5 ion channels. J Biol Chem 286: 33436-33446.
234. Millqvist E, (2011). The airway sensory hyperreactivity syndrome. Pulm Pharmacol 24: 263-266.
235. Minke B, (2010). The history of the Drosophila TRP channel: the birth of a new channel superfamily. J Neurogenet 24: 216-233.
236. Miranda A, Nordstrom E, Mannem A, Smith C, Banerjee B, Sengupta JN, (2007). The role of transient receptor potential vanilloid 1 in mechanical and chemical visceral hyperalgesia following experimental colitis. Neuroscience 148: 1021-1032.
237. Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, et al. (1996). PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272: 1339-1342.
238. Mochizuki T, Sokabe T, Araki I, Fujishita K, Shibasaki K, Uchida K, et al. (2009). The TRPV4 cation channel mediates stretch-evoked Ca2+ influx and ATP release in primary urothelial cell cultures. J Biol Chem 284: 21257-21264.
239. Möller CC, Wei C, Altintas MM, Li J, Greka A, Ohse T, et al. (2007). Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol 18: 29-36.
240. Monet M, Gkika D, Lehen'kyi V, Pourtier A, Vanden Abeele F, Bidaux G, et al. (2009). Lysophospholipids stimulate prostate cancer cell migration via TRPV2 channel activation. Biochim Biophys Acta 1793: 528-539.
241. 2+nificent TRPM chanzymes. Curr Biol 13: R799-R801.
242. Montell C, Rubin GM, (1989). Molecular characterization of the Drosophila trp locus: a putative integral membrane protein required for phototransduction. Neuron 2: 1313-1323.
243. Moqrich A, Hwang SW, Earley TJ, Petrus MJ, Murray AN, Spencer KS, et al. (2005). Impaired thermosensation in mice lacking TRPV3, a heat and camphor sensor in the skin. Science 307: 1468-1472.
244. Moran MM, McAlexander MA, Bírõ T, Szallasi A, (2011). Transient receptor potential channels as therapeutic targets. Nat Rev Drug Discov 10: 601-620.
245. Morelli MB, Amantini C, Liberati S, Santoni M, Nabissi M, (2013). TRP channels: new potential therapeutic approaches in CNS neuropathies. CNS Neurol Disord Drug Targets 12: 274-293.
246. Motter AL, Ahern GP, (2008). TRPV1-null mice are protected from diet-induced obesity. FEBS Lett 582: 2257-2262.
247. Moussaieff A, Rimmerman N, Bregman T, Straiker A, Felder CC, Shoham S, et al. (2008). Incensole acetate, an incense component, elicits psychoactivity by activating TRPV3 channels in the brain. FASEB J 22: 3024-3034.
248. Mukerji G, Yiangou Y, Corcoran SL, Selmer IS, Smith GD, Benham CD, et al. (2006a). Cool and menthol receptor TRPM8 in human urinary bladder disorders and clinical correlations. BMC Urol 6: 6.
249. Mukerji G, Waters J, Chessell IP, Bountra C, Agarwal SK, Anand P, (2006b). Pain during ice water test distinguishes clinical bladder hypersensitivity from overactivity disorders. BMC Urol 6: 31.
250. Mukhopadhyay I, Gomes P, Aranake S, Shetty M, Karnik P, Damle M, et al. (2011). Expression of functional TRPA1 receptor on human lung fibroblasts and epithelial cells. J Recept Signal Transduct Res 31: 350-358.
251. Nakayama H, Wilkin BJ, Bodi I, Molkentin JD, (2006). Calcineurin- dependent cardiomyopathy is activated by TRPC in the adult mouse heart. FASEB J 20: 1660-1670.
252. Nassini R, Materazzi S, Vriens J, Prenen J, Benemei S, De Siena G, et al. (2012a). The 'headache tree' via umbellulone and TRPA1 activates the trigeminovascular system. Brain 135: 376-390.
253. Nassini R, Pedretti P, Moretto N, Fusi C, Carnini C, Facchinetti F, et al. (2012b). Transient receptor potential ankyrin 1 channel localized to non-neuronal airway cells promotes non-neurogenic inflammation. PLoS One 7: e42454.
254. Nassini R, Benemei S, Fusi C, Trevisan dos Santos G, Materazzi S, (2013). Transient receptor potential channels in chemotherapy-induced neuropathy. Open Pain J 5: 32-37.
255. Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, Li X, et al. (2003). Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet 33: 129-137.
256. Naylor J, Milligan CJ, Zeng F, Jones C, Beech DJ, (2008). Production of a specific extracellular inhibitor of TRPM3 channels. Br J Pharmacol 155: 567-573.
257. Naziroǧlu M, Lückhoff A, Jüngling E, (2007). Antagonist effect of flufenamic acid on TRPM2 cation channels activated by hydrogen peroxide. Cell Biochem Funct 25: 383-387.
258. Nelson PL, Beck A, Chen H, (2011). Transient receptor proteins illuminated: current views on TRPs and disease. Vet J 187: 153-164.
259. Nieto-Posadas A, Jara-Oseguera A, Rosenbaum T, (2011a). TRP channel gating physiology. Curr Top Med Chem 11: 2131-2150.
260. Nieto-Posadas A, Picazo-Juárez G, Llorente I, Jara-Oseguera A, Morales-Lázaro S, Escalante-Alcalde D, et al. (2011b). Lysophosphatidic acid directly activates TRPV1 through a C-terminal binding site. Nat Chem Biol 8: 78-85.
261. Nilius B, (2013). Transient receptor potential TRP channels as therapeutic drug targets: next round! Curr Top Med Chem 13: 244-246.
262. Nilius B, Appendino G, (2013). Spices: the savory and beneficial science of pungency. Rev Physiol Biochem Pharmacol 164: 1-76.
263. Nilius B, Bírõ T, (2013). TRPV3: a 'more than skinny' channel. Exp Dermatol 22: 447-452.
264. Nilius B, Owsianik G, (2010). Transient receptor potential channelopathies. Pflugers Arch 460: 437-450.
265. Nilius B, Owsianik G, (2011). The transient receptor potential family of ion channels. Genome Biol 12: 218-229.
266. Nilius B, Voets T, (2013). The puzzle of TRPV4 channelopathies. EMBO Rep 14: 152-163.
267. Nilius B, Prenen J, Owsianik G, (2011). Irritating channels: the case of TRPA1. J Physiol 589: 1543-1549.
268. Nomoto Y, Yoshida A, Ikeda S, Kamikawa Y, Harada K, Ohwatashi A, et al. (2008). Effect of menthol on detrusor smooth-muscle contraction and the micturition reflex in rats. Urology 72: 701-705.
269. Nyman E, Franzén B, Nolting A, Klement G, Liu G, Nilsson M, et al. (2013). In vitro pharmacological characterization of a novel TRPA1 antagonist and proof of mechanism in a human dental pulp model. J Pain Res 6: 59-70.
270. O'Conor CJ, Griffin TM, Liedtke W, Guilak F, (2013). Increased susceptibility of Trpv4-deficient mice to obesity and obesity-induced osteoarthritis with very high-fat diet. Ann Rheum Dis 72: 300-304.
271. Ohba T, Watanabe H, Murakami M, Takahashi Y, (2007). Upregulation of TRPC1 in the development of cardiac hypertrophy. J Mol Cell Cardiol 42: 498-507.
272. Ohkawara S, Tanaka-Kagawa T, Furukawa Y, Jinno H, (2012). Methylglyoxal activates the human transient receptor potential ankyrin 1 channel. J Toxicol Sci 37: 831-835.
273. Okun A, Liu P, Davis P, Ren J, Remeniuk B, Brion T, et al. (2012). Afferent drive elicits ongoing pain in a model of advanced osteoarthritis. Pain 153: 924-933.
274. Onohara N, Nishida M, Inoue R, Kobayashi H, Sumimoto H, Sato Y, et al. (2006). TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy. EMBO J 25: 5305-5316.
275. Owsianik G, D'hoedt D, Voets T, Nilius B, (2006). Structure-function relationship of the TRP channel superfamily. Rev Physiol Biochem Pharmacol 156: 61-90.
276. Palmer RK, Atwal K, Bakaj I, Carlucci-Derbyshire S, Buber MT, Cerne R, et al. (2010). Triphenylphosphine oxide is a potent and selective inhibitor of the transient receptor potential melastatin-5 ion channel. Assay Drug Dev Technol 8: 703-713.
277. Park CK, Xu ZZ, Liu T, Lü N, Serhan CN, Ji RR, (2011a). Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1. J Neurosci 31: 18433-18438.
278. Park HW, Kim JY, Choi SK, Lee YH, Zeng W, Kim KH, et al. (2011b). Serine-threonine kinase with-no-lysine 4 (WNK4) controls blood pressure via transient receptor potential canonical 3 (TRPC3) in the vasculature. Proc Natl Acad Sci U S A 108: 10750-11075.
279. Parks DJ, Parsons WH, Colburn RW, Meegalla SK, Ballentine SK, Illig CR, et al. (2011). Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonists. J Med Chem 54: 233-247.
280. Parnas M, Peters M, Dadon D, Lev S, Vertkin I, Slutsky I, et al. (2009). Carvacrol is a novel inhibitor of Drosophila TRPL and mammalian TRPM7 channels. Cell Calcium 45: 300-309.
281. Patapoutian A, Tate S, Woolf CJ, (2009). Transient receptor potential channels: targeting pain at the source. Nat Rev Drug Discov 8: 55-69.
282. Patwardhan AM, Scotland PE, Akopian AN, Hargreaves KM, (2009). Activation of TRPV1 in the spinal cord by oxidized linoleic acid metabolites contributes to inflammatory hyperalgesia. Proc Natl Acad Sci U S A 106: 18820-18824.
283. Pearce LV, Petukhov PA, Szabo T, Kedei N, Bizik F, Kozikowski AP, et al. (2004). Evodiamine functions as an agonist for the vanilloid receptor TRPV1. Org Biomol Chem 2: 2281-2286.
284. Pedersen SF, Nilius B, (2007). Transient receptor potential channels in mechanosensing and cell volume regulation. Methods Enzymol 428: 183-207.
285. Peier AM, Moqrich A, Hergarden AC, Reeve AJ, Andersson DA, Story GM, et al. (2002a). A TRP channel that senses cold stimuli and menthol. Cell 108: 705-715.
286. Peier AM, Reeve AJ, Andersson DA, Moqrich A, Earley TJ, Hergarden AC, et al. (2002b). A heat-sensitive TRP channel expressed in keratinocytes. Science 296: 2046-2049.
287. Perraud AL, Takanishi CL, Shen B, Kang S, Smith MK, Schmitz C, et al. (2005). Accumulation of free ADP-ribose from mitochondria mediates oxidative stress-induced gating of TRPM2 cation channels. J Biol Chem 280: 6138-6148.
288. Peters DJ, Spruit L, Saris JJ, Ravine D, Sandkuijl LA, Fossdal R, et al. (1993). Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease. Nat Genet 5: 359-362.
289. Petrus M, Peier AM, Bandell M, Hwang SW, Huynh T, Olney N, et al. (2007). A role of TRPA1 in mechanical hyperalgesia is revealed by pharmacological inhibition. Mol Pain 3: 40.
290. Pingle SC, Matta JA, Ahern GP, (2007). Capsaicin receptor: TRPV1 a promiscuous TRP channel. Handb Exp Pharmacol 179: 155-171.
291. Planells-Cases R, Ferrer-Montiel A, (2007). TRP channel trafficking. In:, Liedtke WB, Heller S, (eds). TRP Ion Channel Function in Sensory Transduction and Cellular Signaling Cascades. CRC Press, Taylor & Francis: Boca Raton, FL, pp. 319-330.
292. Plato CC, Galasko D, Garruto RM, Plato M, Gamst A, Craig UK, et al. (2002). ALS and PDC of Guam: 40-year follow-up. Neurology 58: 765-773.
293. Preti D, Szallasi A, Patacchini R, (2012). TRP channels as therapeutic targets in airway disorders: a patent review. Expert Opin Ther Pat 22: 663-695.
294. Puttfarcken PS, Han P, Joshi SK, Neelands TR, Gauvin DM, Baker SJ, et al. (2010). A-995662 [R-8-(4-methyl-5-(4-(trifluoromethyl)phenyl)oxazol-2-ylamino)- 1,2,3,4-tetrahydronaphthalen-2-ol], a novel, selective TRPV1 receptor antagonist, reduces spinal release of glutamate and CGRP in a rat knee joint pain model. Pain 150: 319-326.
295. Qin N, Neeper MP, Liu Y, Hutchinson TL, Lubin ML, Flores CM, (2008). TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. J Neurosci 28: 6231-6238.
296. Qin X, Yue Z, Sun B, Yang W, Xie J, Ni E, et al. (2013). Sphingosine and FTY720 are potent inhibitors of the transient receptor potential melastatin 7 (TRPM7) channels. Br J Pharmacol 168: 1294-1312.
297. Ramachandran R, Hyun E, Zhao L, Lapointe TK, Chapman K, Hirota CL, et al. (2013). TRPM8 activation attenuates inflammatory responses in mouse models of colitis. Proc Natl Acad Sci USA 110: 7476-7481.
298. Raychowdhury MK, González-Perrett S, Montalbetti N, Timpanaro GA, Chasan B, Goldmann WH, et al. (2004). Molecular pathophysiology of mucolipidosis type IV: pH dysregulation of the mucolipin-1 cation channel. Hum Mol Genet 13: 617-627.
299. Razavi R, Chan Y, Afifiyan FN, Liu XJ, Wan X, Yantha J, et al. (2006). TRPV1+ sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes. Cell 127: 1123-1135.
300. Reiser J, Polu KR, Möller CC, Kenlan P, Altintas MM, Wei C, et al. (2005). TRPC6 is a glomerular slit diaphragm-Associated channel required for normal renal function. Nat Genet 37: 739-744.
301. Riccio A, Li Y, Moon J, Kim KS, Smith KS, Rudolph U, et al. (2009). Essential role for TRPC5 in amygdala function and fear-related behavior. Cell 137: 761-772.
302. Romano B, Borrelli F, Fasolino I, Capasso R, Piscitelli F, Cascio M, et al. (2013). The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis. Br J Pharmacol 169: 213-229.
303. Romero JR, Germer S, Castonguay AJ, Barton NS, Martin M, Zee RY, (2010). Gene variation of the transient receptor potential cation channel, subfamily M, member 2 (TRPM2) and type 2 diabetes mellitus: a case-control study. Clin Chim Acta 411: 1437-1440.
304. Round P, Priestly A, Robinson J, (2011). An investigation of the safety and pharmacokinetics of the novel TRPV1 antagonist XEN-D0501 in healthy subject. Br J Clin Pharmacol 72: 921-931.
305. Rowbotham MC, Nothaft W, Duan WR, Wang Y, Faltynek C, McGaraughty S, et al. (2011). Oral and cutaneous thermosensory profile of selective TRPV1 inhibition by ABT-102 in a randomized healthy volunteer trial. Pain 152: 1192-1200.
306. Ryckmans T, Aubdool AA, Bodkin JV, Cox P, Brain SD, Dupont T, et al. (2011). Design and pharmacological evaluation of PF-4840154, a non-electrophilic reference agonist of the TrpA1 channel. Bioorg Med Chem Lett 21: 4857-4859.
307. Saldanha SA, Grimm C, Mercer BA, Choi JY, Allais C, Roush WR, et al. (2010-2009). Campaign to Identify Agonists of Transient Receptor Potential Channels 3 and 2 (TRPML3 & TRPML2). Reports from the NIH Molecular Libraries Program [Internet]. National Center for Biotechnology Information (US): Bethesda, MD.
308. Santoni G, Farfariello V, (2011). TRP channels and cancer: new targets for diagnosis and chemotherapy. Endocr Metab Immune Disord Drug Targets 11: 54-67.
309. Santos-Silva A, Charrua A, Cruz CD, Gharat L, Avelino A, Cruz F, (2012). Rat detrusor overactivity induced by chronic spinalization can be abolished by a transient receptor potential vanilloid 1 (TRPV1) antagonist. Auton Neurosci 166: 35-38.
310. Schattling B, Steinbach K, Thies E, Kruse M, Menigoz A, Ufer F, et al. (2012). TRPM4 cation channel mediates axonal and neuronal degeneration in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 18: 1805-1811.
311. Schleifer H, Doleschal B, Lichtenegger M, Oppenrieder R, Derler I, Frischauf I, et al. (2012). Novel pyrazole compounds for pharmacological discrimination between receptor-operated and store-operated Ca(2+) entry pathways. Br J Pharmacol 167: 1712-1722.
312. Schulze A, Oehler B, Urban N, Schaefer M, Hill K, (2013). Apomorphine is a bimodal modulator of TRPA1 channels. Mol Pharmacol 83: 542-551.
313. Schwartz EC, Wolfs MJ, Tonner S, Wenning AS, Quintana A, Griesemer D, et al. (2007). TRP channels in lymphocytes. Hand Exp Pharmacol 179: 445-456.
314. Seabrook GR, Sutton KG, Jarolimek W, Hollingworth GJ, Teague S, Webb J, et al. (2002). Functional properties of the high-Affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin. J Pharmacol Exp Ther 303: 1052-1060.
315. Seth M, Zhang ZS, Mao L, Graham V, Burch J, Stiber J, et al. (2009). TRPC1 channels are critical for hypertrophic signaling in the heart. Circ Res 105: 1023-1030.
316. Shen D, Wang X, Li X, Zhang X, Yao Z, Dibble S, et al. (2012). Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release. Nat Commun 3: 731.
317. Sherkheli MA, Vogt-Eisele AK, Bura D, Beltrán Márques LR, Gisselmann G, Hatt H, (2010). Characterization of selective TRPM8 ligands and their structure activity response (S.A.R.) relationship. J Pharm Pharm Sci 13: 242-253.
318. Shibata Y, Ugawa S, Imura M, Kubota Y, Ueda T, Kojima Y, et al. (2011). TRPM8-expressing dorsal root ganglion neurons project dichotomizing axons to both skin and bladder in rats. Neuroreport 22: 61-67.
319. Shim WS, Tak MH, Lee MH, Kim M, Kim M, Koo JY, et al. (2007). TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase. J Neurosci 27: 2331-2337.
320. Shintaku K, Uchida K, Suzuki Y, Zhou Y, Fushiki T, Watanabe T, et al. (2012). Activation of transient receptor potential A1 by a non-pungent capsaicin-like compound, capsiate. Br J Pharmacol 165: 1476-1486.
321. Siemens J, Zhou S, Piskorowski R, Nikai T, Lumpkin EA, Basbaum AI, et al. (2006). Spider toxins activate the capsaicin receptor to produce inflammatory pain. Nature 444: 208-212.
322. Singh BB, Pabelick CM, Prakash YS, (2012). Canonical transient receptor potential channel expression, regulation and function. TRP Channels in Drug Discovery., Szallasi A, Bírõ T,. Methods in Pharmacology and Toxicology, Springer Protocols. Humana Press/Springer: New York, Heidelberg, Dordrecht, London, pp. 61-88.
323. Siroky BJ, Ferguson WB, Fuson AL, Xie Y, Fintha A, Komlosi P, et al. (2006). Loss of primary cilia results in deregulated and unabated apical calcium entry in ARPKD collecting duct cells. Am J Physiol Renal Physiol 290: F1320-F1328.
324. Skryma R, Prevarskaya N, Gkika D, Shuba Y, (2011). From urgency to frequency: facts and controversies of TRPs in the lower urinary tract. Nat Rev Urol 8: 617-630.
325. Smit LA, Kogevinas M, Antõ JM, Bouzigon E, González JR, Le Moual N, et al. (2012). Transient receptor potential genes, smoking, occupational exposures and cough in adults. Respir Res 13: 26.
326. Smith AC, Parajuli SP, Hristov KL, Cheng Q, Soder RP, Afeli SA, et al. (2013a). TRPM4 channel: a new player in urinary bladder smooth muscle function in rats. Am J Physiol Renal Physiol 304: F918-F929.
327. Smith AC, Hristov KL, Cheng Q, Xin W, Parajuli SP, Earley S, et al. (2013b). Novel role for the transient potential receptor melastatin 4 channel in guinea pig detrusor smooth muscle physiology. Am J Physiol Cell Physiol 304: C467-C477.
328. Smith PK, Nilius B, (2013). Transient receptor potentials (TRPs) and anaphylaxis. Curr Allergy Asthma Res 13: 93-100.
329. Smith PL, Maloney KN, Pothen RG, Clardy J, Clapham DE, (2006). Bisandrographolide from Andrographis paniculata activates TRPV4 channels. J Biol Chem 281: 29897-29904.
330. Spassova MA, Hewavitharana T, Xu W, Soboloff J, Gill DL, (2006). A common mechanism underlies stretch activation and receptor activation of TRPC6 channels. Proc Natl Acad Sci U S A 103: 16586-16591.
331. Spina D, Page CP, (2013). Regulating cough through modulation of sensory nerve function in the airways. Pulm Pharmacol Ther 26: 486-490.
332. Stallmeyer B, Zumhagen S, Denjoy I, Duthoit G, Hébert JL, Ferrer X, et al. (2012). Mutational spectrum in the Ca(2+)-Activated cation channel gene TRPM4 in patients with cardiac conductance disturbances. Hum Mutat 33: 109-117.
333. Stokes A, Wakano C, Koblan-Huberson M, Adra CN, Fleig A, Turner H, (2006). TRPA1 is a substrate for de-ubiquitination by the tumor suppressor CYLD. Cell Signal 18: 1584-1594.
334. Story GM, Peier AM, Reeve AJ, Eid SR, Mosbacher J, Hricik TR, et al. (2003). ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 112: 819-829.
335. Straub I, Mohr F, Stab J, Konrad M, Philipp SE, Oberwinkler J, et al. (2013). Citrus fruit and fabacea secondary metabolites potently and selectively block TRPM3. Br J Pharmacol 168: 1835-1850.
336. Streng T, Axelsson HE, Hedlund P, Andersson DA, Jordt SE, Bevan S, et al. (2008). Distribution and function of the hydrogen sulfide-sensitive TRPA1 ion channel in rat urinary bladder. Eur Urol 53: 391-399.
337. Sun HS, Jackson MF, Martin LJ, Jansen K, Teves L, Cui H, et al. (2009). Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia. Nat Neurosci 12: 1300-1307.
338. Sun M, Goldin E, Stahl S, Falardeau JL, Kennedy JC, Acierno JS Jr, et al. (2000). Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. Hum Mol Genet 9: 2471-2478.
339. Suri A, Szallasi A, (2008). The emerging role of TRPV1 in diabetes and obesity. Trends Pharmacol Sci 29: 29-36.
340. Suzuki M, Mizuno A, Kodaira K, Imai M, (2003). Impaired pressure sensation in mice lacking TRPV4. J Biol Chem 278: 22664-22668.
341. Szabõ A, Helyes Z, Sándor K, Bite A, Pintér E, Németh J, et al. (2005). Role of transient receptor potential vanilloid 1 receptors in adjuvant-induced chronic arthritis: in vivo study using gene-deficient mice. J Pharmacol Exp Ther 314: 111-119.
342. Szallasi A, Blumberg PM, (1989). Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper. Neuroscience 30: 515-520.
343. Szallasi A, Blumberg PM, (1999). Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 51: 159-212.
344. Szallasi A, Blumberg PM, (2006). Complex regulation of TRPV1 by vanilloids. In:, Heller S, Liedtke W, (eds). TRP Ion Channel Function in Sensory Transduction and Cellular Signaling Cascades. CRC Press: Boca Raton, FL, pp. 85-104.
345. Szallasi A, Sheta M, (2012). Targeting TRPV1 for pain relief: limits, losers and laurels. Expert Opin Investig Drugs 21: 1351-1369.
346. Szallasi A, Cortright DN, Bloom CA, Eid SR, (2007). The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov 6: 357-372.
347. Szolcsányi J, Sándor Z, (2012). Multisteric TRPV1 nocisensor: a target for analgesics. Trends Pharmacol Sci 33: 646-655.
348. Tai Y, Feng S, Ge R, Du W, Zhang X, He Z, et al. (2008). TRPC6 channels promote dendritic growth via the CaMKIV-CREB pathway. J Cell Sci 121: 2301-2307.
349. Takezawa R, Cheng H, Beck A, Ishikawa J, Launay P, Kubota H, et al. (2006). A pyrazole derivative potently inhibits lymphocyte Ca2+ influx and cytokine production by facilitating transient receptor potential melastatin 4 channel activity. Mol Pharmacol 69: 1413-1420.
350. Tamayo NA, Bo Y, Gore V, Ma V, Nishimura N, Tang P, et al. (2012). Fused piperidines as a novel class of potent and orally available transient receptor potential melastatin type 8 (TRPM8) antagonists. J Med Chem 55: 1593-1611.
351. Tanaka H, Shimaya A, Kiso T, Kuramochi T, Shimokawa T, Shibasaki M, (2011). Enhanced insulin secretion and sensitization in diabetic mice on chronic treatment with a transient receptor potential vanilloid 1 antagonist. Life Sci 88: 559-563.
352. Taylor-Clark TE, Undem BJ, (2010). Ozone activates airway nerves via the selective stimulation of TRPA1 ion channels. J Physiol 588: 423-433.
353. Taylor-Clark TE, Undem BJ, Macglashan DW Jr, Ghatta S, Carr MJ, McAlexander MA, (2008a). Prostaglandin-induced activation of nociceptive neurons via direct interaction with transient receptor potential A1 (TRPA1). Mol Pharmacol 73: 274-281.
354. Taylor-Clark TE, McAlexander MA, Nassenstein C, Sheardown SA, Wilson S, Thornton J, et al. (2008b). Relative contributions of TRPA1 and TRPV1 channels in the activation of vagal bronchopulmonary C-fibres by the endogenous autacoid 4-oxononenal. J Physiol 586: 3447-3459.
355. Taylor-Clark TE, Ghatta S, Bettner W, Undem BJ, (2009). Nitrooleic acid, an endogenous product of nitrative stress, activates nociceptive sensory nerves via the direct activation of TRPA1. Mol Pharmacol 75: 820-829.
356. Ternesten-Hassèus E, Larsson C, Bende M, Millqvist E, (2008). Capsaicin provocation using two different inhalation devices. Respir Med 102: 1784-1790.
357. Thilo F, Loddenkemper C, Berg E, Zidek W, Tepel M, (2009). Increased TRPC3 expression in vascular endothelium of patients with malignant hypertension. Mod Pathol 22: 426-430.
358. Thorneloe KS, Sulpizio AC, Lin Z, Figueroa DJ, Clouse AK, McCafferty GP, et al. (2008). N-( (1S)-1-{[4-((2S)-2-{ [ (2,4-dichlorophenyl)sulfonyl]amino}-3- hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2- carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: part I. J Pharmacol Exp Ther 326: 432-442.
359. Thorneloe KS, Cheung M, Bao W, Alsaid H, Lenhard S, Jian MY, et al. (2012). An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failure. Sci Transl Med 4: 159ra148.
360. Tian D, Jacobo SM, Billing D, Rozkalne A, Gage SD, Anagnostou T, et al. (2010). Antagonistic regulation of actin dynamics and cell motility by TRPC5 and TRPC6 channels. Sci Signal 3: ra77.
361. Todaka H, Taniguchi J, Satoh J, Mizuno A, Suzuki M, (2004). Warm temperature-sensitive transient receptor potential vanilloid 4 (TRPV4) plays an essential role in thermal hyperalgesia. J Biol Chem 279: 35133-35138.
362. Togashi K, Inada H, Tominaga M, (2008). Inhibition of the transient receptor potential cation channel TRPM2 by 2-Aminoethoxydiphenyl borate (2-APB). Br J Pharmacol 153: 1324-1330.
363. Tominaga M, (2007). The role of TRP channels in thermosensation. In:, Liedtke WB, Heller S, (eds). TRP Ion Channel Function in Sensory Transduction and Cellular Signaling Cascades. CRC Press, Taylor & Francis: Boca Raton, FL, pp. 271-286.
364. Toth A, Kedei N, Szabo T, Wang Y, Blumberg PM, (2002). Thapsigargin binds to and inhibits the cloned vanilloid receptor-1. Biochem Biophys Res Commun 293: 777-782.
365. Tõth BI, Dobrosi N, Dajnoki A, Czifra G, Oláh A, Szöllosi AG, et al. (2011). Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1. J Invest Dermatol 131: 1095-1104.
366. Trevisani M, Patacchini R, Nicoletti P, Gatti R, Gazzieri D, Lissi N, et al. (2005). Hydrogen sulfide causes vanilloid receptor 1-mediated neurogenic inflammation in the airways. Br J Pharmacol 145: 1123-1131.
367. Trevisani M, Siemens J, Materazzi S, Bautista DM, Nassini R, Campi B, et al. (2007). 4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1. Proc Natl Acad Sci U S A 104: 13519-13524.
368. Tsui H, Razavi R, Chan Y, Yantha J, Dosch HM, (2007). 'Sensing' autoimmunity in type 1 diabetes. Trends Mol Med 13: 405-413.
369. Tsui H, Paltser G, Chan Y, Dorfman R, Dosch HM, (2011). 'Sensing' the link between type 1 and type 2 diabetes. Diabetes Metab Res Rev 27: 913-918.
370. Uchida K, Dezaki K, Damdindorj B, Inada H, Shiuchi T, Mori Y, et al. (2011). Lack of TRPM2 impaired insulin secretion and glucose metabolisms in mice. Diabetes 60: 119-126.
371. Valdes AM, De Wilde G, Doherty SA, Lories RJ, Vaughn FL, Laslett LL, et al. (2011). The Ile585Val TRPV1 variant is involved in risk of painful knee osteoarthritis. Ann Rheum Dis 70: 1556-1561.
372. Valenzano KJ, Grant ER, Wu G, Hachicha M, Schmid L, Tafesse L, et al. (2003). N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine- 1(2H)-carbox-Amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties. J Pharmacol Exp Ther 306: 377-386.
373. Vay L, Gu C, McNaughton PA, (2012). The thermoTRP ion channel family: properties and therapeutic implications. Br J Pharmacol 165: 787-801.
374. Vennekens R, Menigoz A, Nilius B, (2012). TRPs in the brain. Rev Physiol Biochem Pharmacol 163: 27-64.
375. Vergarajauregui S, Puertollano R, (2008). Mucolipidosis type IV: the importance of functional lysosomes for efficient autophagy. Autophagy 4: 832-834.
376. Vetter I, Touska F, Hess A, Hinsbey R, Sattler S, Lampert A, et al. (2012). Ciguatoxins activate cold pathways to elicit burning pain from cooling. EMBO J 31: 3795-3808.
377. Vincent F, Acevedo A, Nguyen MT, Dourado M, DeFalco J, Gustafson A, et al. (2009). Identification and characterization of novel TRPV4 modulators. Biochem Biophys Res Commun 389: 490-494.
378. Vindis C, D'Angelo R, Mucher E, Nègre-Salvayre A, Parini A, Mialet-Perez J, (2010). Essential role of TRPC1 channels in cardiomyoblasts hypertrophy mediated by 5-HT2A serotonin receptors. Biochem Biophys Res Commun 391: 979-983.
379. Vogt-Eisele AK, Weber K, Sherkheli MA, Vielhaber G, Panten J, Gisselmann G, et al. (2007). Monoterpenoid agonists of TRPV3. Br J Pharmacol 151: 530-540.
380. Vriens J, Nilius B, Vennekens R, (2008). Herbal compounds and toxins modulating TRP channels. Curr Neuropharmacol 6: 79-96.
381. Vriens J, Owsianik G, Hofmann T, Philipp SE, Stab J, Chen X, et al. (2011). TRPM3 is a nociceptor channel involved in the detection of noxious heat. Neuron 70: 482-494.
382. Wagner TF, Loch S, Lambert S, Straub I, Mannebach S, Mathar I, et al. (2008). Transient receptor potential M3 channels are ionotropic steroid receptors in pancreatic beta cells. Nat Cell Biol 10: 1421-1430.
383. Wang P, Yan Z, Zhong J, Chen J, Ni Y, Li L, et al. (2012). Transient receptor potential vanilloid 1 activation enhances gut glucagon-like peptide-1 secretion and improves glucose homeostasis. Diabetes 61: 2155-2165.
384. Wang X, Miyares RL, Ahern GP, (2005). Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1. J Physiol 564: 541-547.
385. Wang Y, Jarad G, Tripathi P, Pan M, Cunningham J, Martin DR, et al. (2010). Activation of NFAT signaling in podocytes causes glomerulosclerosis. J Am Soc Nephrol 21: 1657-1666.
386. Wang ZY, Wang P, Merriam FV, Bjorling DE, (2008). Lack of TRPV1 inhibits cystitis-induced increased mechanical sensitivity in mice. Pain 139: 158-167.
387. Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B, (2003). Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature 424: 434-438.
388. Watanabe H, Iino K, Ohba T, Ito H, (2013). Possible involvement of TRP channels in cardiac hypertrophy and arrhythmia. Curr Top Med Chem 13: 283-294.
389. Wei H, Hämäläinen MM, Saarnilehto M, Koivisto A, Pertovaara A, (2009). Attenuation of mechanical hypersensitivity by an antagonist of the TRPA1 ion channel in diabetic animals. Anesthesiology 111: 147-154.
390. Weissmann N, Dietrich A, Fuchs B, Kalwa H, Ay M, Dumitrascu R, et al. (2006). Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange. Proc Natl Acad Sci U S A 103: 19093-19098.
391. Weissmann N, Sydykov A, Kalwa H, Storch U, Fuchs B, Mederos y Schnitzler M, et al. (2012). Activation of TRPC6 channels is essential for lung ischaemia-reperfusion induced oedema in mice. Nat Commun 3: 649.
392. Wes PD, Chevesich J, Jeromin A, Rosenberg C, Stetten G, Montell C, (1995). TRPC1, a human homolog of a Drosophila store-operated channel. Proc Natl Acad Sci USA 92: 9652-9656.
393. Willette RN, Bao W, Nerurkar S, Yue TL, Doe CP, Stankus G, et al. (2008). Systemic activation of the transient receptor potential vanilloid subtype 4 channel causes endothelial failure and circulatory collapse: part 2. J Pharmacol Exp Ther 326: 443-452.
394. Willis DN, Liu B, Ha MA, Jordt SE, Morris JB, (2011). Menthol attenuates respiratory irritation responses to multiple cigarette smoke irritants. FASEB J 25: 4434-4444.
395. Wilson SR, Gerhold KA, Bifolck-Fisher A, Liu Q, Patel KN, et al. (2011). TRPA1 is required for histamine-independent, Mas-related G protein-coupled receptor-mediated itch. Nat Neurosci 14: 595-602.
396. Winn MP, Conlon PJ, Lynn KL, Farrington MK, Creazzo T, Hawkins AF, et al. (2005). A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308: 1801-1804.
397. Wu LJ, Sweet TB, Clapham DE, (2010). International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family. Pharmacol Rev 62: 381-404.
398. Xing H, Ling JX, Chen M, Johnson RD, Tominaga M, Wang CY, et al. (2008). TRPM8 mechanism of autonomic nerve response to cold in respiratory airway. Mol Pain 4: 22.
399. Xu H, Ramsey IS, Kotecha SA, Moran MM, Chong JA, Lawson D, et al. (2002). TRPV3 is a calcium-permeable temperature-sensitive cation channel. Nature 418: 181-186.
400. Xu H, Blair NT, Clapham DE, (2005). Camphor activates and strongly desensitizes the transient receptor potential vanilloid subtype 1 channel in a vanilloid-independent mechanism. J Neurosci 25: 8924-8937.
401. Xu H, Delling M, Jun JC, Clapham DE, (2006a). Oregano, thyme and clove-derived flavors and skin sensitizers activate specific TRP channels. Nat Neurosci 9: 628-635.
402. Xu SZ, Muraki K, Zeng F, Li J, Sukumar P, Shah S, et al. (2006b). A sphingosine-1-phosphate-Activated calcium channel controlling vascular smooth muscle cell motility. Circ Res 98: 1381-1389.
403. Yamaguchi T, Hempson SJ, Reif GA, Hedge AM, Wallace DP, (2006). Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells. J Am Soc Nephrol 17: 178-187.
404. Yang H, Zhao B, Liao C, Zhang R, Meng K, Xu J, et al. (2013). High glucose-induced apoptosis in cultured podocytes involves TRPC6-dependent calcium entry via the RhoA/ROCK pathway. Biochem Biophys Res Commun 434: 394-400.
405. Yang J, Li Y, Zuo X, Zhen Y, Yu Y, Gao L, (2008). Transient receptor potential ankyrin-1 participates in visceral hyperalgesia following experimental colitis. Neurosci Lett 440: 237-241.
406. Ye L, Kleiner S, Wu J, Sah R, Gupta RK, Banks AS, et al. (2012). TRPV4 is a regulator of adipose oxidative metabolism, inflammation, and energy homeostasis. Cell 151: 96-110.
407. Yiangou Y, Facer P, Dyer NH, Chan NL, Knowles C, Williams NS, et al. (2001). Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet 357: 1338-1339.
408. Yoshioka T, Imura K, Asakawa M, Suzuki M, Oshima I, Hirasawa T, et al. (2009). Impact of the Gly573Ser substitution in TRPV3 on the development of allergic and pruritic dermatitis in mice. J Invest Dermatol 129: 714-722.
409. Yu W, Hill WG, Apodaca G, Zeidel ML, (2011). Expression and distribution of transient receptor potential (TRP) channels in bladder epithelium. Am J Physiol Renal Physiol 300: F49-F59.
410. Yu Y, Fantozzi I, Remillard CV, Landsberg JW, Kunichika N, Platoshyn O, et al. (2004). Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension. Proc Natl Acad Sci U S A 101: 13861-13866.
411. Yu Y, Keller SH, Remillard CV, Safrina O, Nicholson A, Zhang SL, et al. (2009a). A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertension. Circulation 119: 2313-2322.
412. Yu Y, Ulbrich MH, Li MH, Buraei Z, Chen XZ, Ong AC, et al. (2009b). Structural and molecular basis of the assembly of the TRPP2/PKD1 complex. Proc Natl Acad Sci U S A 106: 11558-11563.
413. Zhang X, Li L, McNaughton PA, (2008). Proinflammatory mediators modulate the heat-Activated ion channel TRPV1 via the scaffolding protein AKAP79/150. Neuron 59: 450-461.
414. Zhou J, Du W, Zhou K, Tai Y, Yao H, Jia Y, et al. (2008). Critical role of TRPC6 channels in the formation of excitatory synapses. Nat Neurosci 11: 741-743.
415. Zhu B, Xia M, Xu X, Ludovici DW, Tennakoon M, Youngman MA, et al. (2013). Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonists. Bioorg Med Chem Lett 23: 2234-2237.
416. Zhu G, ICGN Investigators, Gulsvik A, Bakke P, Ghatta S, Anderson W, Lomas DA, et al. (2009). Association of TRPV4 gene polymorphisms with chronic obstructive pulmonary disease. Hum Mol Genet 18: 2053-2062.
417. Zhu X, Chu PB, Peyton M, Birnbaumer L, (1995). Molecular cloning of a widely expressed human homologue for the Drosophila trp gene. FEBS Lett 373: 193-198.
418. Zhu Z, Luo Z, Ma S, Liu D, (2011). TRP channels and their implications in metabolic diseases. Pflugers Arch 461: 211-223.
419. Zierler S, Yao G, Zhang Z, Kuo WC, Pörzgen P, Penner R, et al. (2011). Waixenicin A inhibits cell proliferation through magnesium-dependent block of transient receptor potential melastatin 7 (TRPM7) channels. J Biol Chem 286: 39328-39335.
420. Zimmermann K, Lennerz JK, Hein A, Link AS, Kaczmarek JS, Delling M, et al. (2011). Transient receptor potential channel, subfamily C, member 5 (TRPC5) is a cold-transducer in the peripheral nervous system. Proc Natl Acad Sci USA 108: 18114-18119.
421. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sørgård M, Di Marzo V, et al. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400: 452-457.